Australia markets close in 5 hours 36 minutes

bluebird bio, Inc. (BLE.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
15.900.00 (0.00%)
At close: 05:13PM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 1.04B
Enterprise value 496.53M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)24.76
Price/book (mrq)1.28
Enterprise value/revenue 105.35
Enterprise value/EBITDA -0.95

Trading information

Stock price history

Beta (5Y monthly) 1.68
52-week change 3-66.64%
S&P500 52-week change 3-7.05%
52-week high 349.99
52-week low 315.31
50-day moving average 320.80
200-day moving average 324.69

Share statistics

Avg vol (3-month) 3103
Avg vol (10-day) 370
Shares outstanding 567.58M
Implied shares outstanding 6N/A
Float 870.85M
% held by insiders 11.16%
% held by institutions 189.83%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)31 Mar 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-11,359.16%

Management effectiveness

Return on assets (ttm)-31.44%
Return on equity (ttm)-76.97%

Income statement

Revenue (ttm)4.71M
Revenue per share (ttm)0.07
Quarterly revenue growth (yoy)117.60%
Gross profit (ttm)-351.14M
EBITDA -534.25M
Net income avi to common (ttm)-563.29M
Diluted EPS (ttm)-9.88
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)211.59M
Total cash per share (mrq)2.96
Total debt (mrq)110.34M
Total debt/equity (mrq)41.91
Current ratio (mrq)1.78
Book value per share (mrq)3.68

Cash flow statement

Operating cash flow (ttm)-557.61M
Levered free cash flow (ttm)-300.22M